Financial Summary (All financials)
| In millions, except per share items | Jan-01-23 | Jan-02-22 | Dec-31-20 |
| Revenues | 6.2 | 0.0 | 0.0 |
| Cost of goods sold | 23.2 | 2.0 | 3.4 |
| Gross profit | -17.0 | -2.0 | -3.4 |
| Gross margin | -274.7% | | |
| Selling, general and administrative | 52.0 | 29.7 | 5.7 |
| Research and development | 58.1 | 37.9 | 14.4 |
| EBIT | -127.1 | -69.5 | -23.5 |
| EBIT margin | -2048.7% | | |
| Pre-tax income | -51.6 | -125.9 | -39.7 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -51.6 | -125.9 | -39.7 |
| Net margin | -832.3% | | |
| |
| Diluted EPS | ($0.33) | ($1.07) | ($0.49) |
| Shares outstanding (diluted) | 154.1 | 117.2 | 80.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|